Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sascha Kiesslich

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Biotechnology Advances|August 10, 2020
Vero cell upstream bioprocess development for the production of viral vectors and vaccinesSascha Kiesslich, Amine A Kamen
Methodsx|March 21, 2020
Titration methods for rVSV-based vaccine manufacturingJean-François Gélinas, Sascha Kiesslich, Rénald Gilbert, et al.
Journal of Biotechnology|February 2, 2020
Serum-free production of rVSV-ZEBOV in Vero cells: Microcarrier bioreactor versus scale-X™ hydro fixed-bedSascha Kiesslich, José Pedro Vila-Chã Losa, Jean-François Gélinas, et al.
Biotechnology and Bioengineering|April 10, 2021
Bioreactor production of rVSV-based vectors in Vero cell suspension culturesSascha Kiesslich, Gyoung N Kim, Chun F Shen, et al.
NPJ Vaccines|August 21, 2021
Haplotype-resolved de novo assembly of the Vero cell line genomeMarie-Angélique Sène, Sascha Kiesslich, Haig Djambazian, et al.
Vaccines|November 27, 2021
Process Development for Newcastle Disease Virus-Vectored Vaccines in Serum-Free Vero Cell Suspension CulturesJulia Puppin Chaves Fulber, Omar Farnós, Sascha Kiesslich, et al.
Vaccine|September 25, 2019
Production of rVSV-ZEBOV in serum-free suspension culture of HEK 293SF cellsJean-François Gélinas, Hiva Azizi, Sascha Kiesslich, et al.
Vaccine|November 3, 2020
Evaluation of novel HIV vaccine candidates using recombinant vesicular stomatitis virus vector produced in serum-free Vero cell culturesMathias Mangion, Jean-François Gélinas, Anahita Bakhshi Zadeh Gashti, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Biotechnology Advances|August 10, 2020
Vero cell upstream bioprocess development for the production of viral vectors and vaccinesSascha Kiesslich, Amine A Kamen
Methodsx|March 21, 2020
Titration methods for rVSV-based vaccine manufacturingJean-François Gélinas, Sascha Kiesslich, Rénald Gilbert, et al.
Journal of Biotechnology|February 2, 2020
Serum-free production of rVSV-ZEBOV in Vero cells: Microcarrier bioreactor versus scale-X™ hydro fixed-bedSascha Kiesslich, José Pedro Vila-Chã Losa, Jean-François Gélinas, et al.
Biotechnology and Bioengineering|April 10, 2021
Bioreactor production of rVSV-based vectors in Vero cell suspension culturesSascha Kiesslich, Gyoung N Kim, Chun F Shen, et al.
NPJ Vaccines|August 21, 2021
Haplotype-resolved de novo assembly of the Vero cell line genomeMarie-Angélique Sène, Sascha Kiesslich, Haig Djambazian, et al.
Vaccines|November 27, 2021
Process Development for Newcastle Disease Virus-Vectored Vaccines in Serum-Free Vero Cell Suspension CulturesJulia Puppin Chaves Fulber, Omar Farnós, Sascha Kiesslich, et al.
Vaccine|September 25, 2019
Production of rVSV-ZEBOV in serum-free suspension culture of HEK 293SF cellsJean-François Gélinas, Hiva Azizi, Sascha Kiesslich, et al.
Vaccine|November 3, 2020
Evaluation of novel HIV vaccine candidates using recombinant vesicular stomatitis virus vector produced in serum-free Vero cell culturesMathias Mangion, Jean-François Gélinas, Anahita Bakhshi Zadeh Gashti, et al.
Pageof 1